인쇄하기
취소
|
It is noticed that a new hyperlipidemia complex drug will soon be launched as interconnecting with the research report proving effectiveness of non-statin type medicines on treating cardiovascular disorders.
According to the Ministry of Food and Drug Safety on the 26th, the MSD’s hyperlipidemia complex drug ‘Atozet’ acquired the sale rights in Korea. It is expected to be launched in the first ...